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Background: Magnetic Resonance-guided High Intensity Focused Ultrasound (MRgHIFU) is a hybrid technology that aims
to offer non-invasive thermal ablation of targeted tumors or other pathological tissues. Acoustic aberrations and non-linear
wave propagating effects may shift the focal point significantly away from the prescribed (or, theoretical) position. It is
therefore mandatory to evaluate the spatial accuracy of ablation for a given HIFU protocol and/or device. We describe
here a method for producing a user-defined ballistic target as an absolute reference marker for MRgHIFU ablations.
Methods: The investigated method is based on trapping a mixture of MR contrast agent and histology stain using
radiofrequency (RF) ablation causing cell death and coagulation. A dedicated RF-electrode was used for the marker fixation
as follows: a RF coagulation (4 W, 15 seconds) and injection of the mixture followed by a second RF coagulation. As a result,
the contrast agent/stain is encapsulated in the intercellular space. Ultrasonography imaging was performed during the
procedure, while high resolution T1w 3D VIBE MR acquisition was used right after to identify the position of the ballistic
marker and hence the target tissue. For some cases, after the marker fixation procedure, HIFU volumetric ablations were
produced by a phased-array HIFU platform. First ex vivo experiments were followed by in vivo investigation on four rabbits
in thigh muscle and six pigs in liver, with follow-up at Day 7.
Results: At the end of the procedure, no ultrasound indication of the marker’s presence could be observed, while it was
clearly visible under MR and could be conveniently used to prescribe the HIFU ablation, centered on the so-created target.
The marker was identified at Day 7 after treatment, immediately after animal sacrifice, after 3 weeks of post-mortem
formalin fixation and during histology analysis. Its size ranged between 2.5 and 4 mm.
Conclusions: Experimental validation of this new ballistic marker method was performed for liver MRgHIFU ablation, free
of any side effects (e.g. no edema around the marker, no infection, no bleeding). The study suggests that the absolute
reference marker had ultrasound conspicuity below the detection threshold, was irreversible, MR-compatible and
MR-detectable, while also being a well-established histology staining technique.
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High Intensity Focused Ultrasound (HIFU) is fundamen-
tally a propagating wave capable of producing localized
thermal lesions [1-3]. A large variety of US transducers,
either single element or phased array, with continuous
or pulsed-mode [4], have been described [5-7] for this
non-invasive approach, proving the growing interest in
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stated.The highest temperature elevation induced by the
HIFU beam is expected to occur around the focal point,
but every penetrated tissue in the pathway of the wave
will also be heated at various levels depending on acous-
tic and physiological properties and on its relative pos-
ition from the transducer. Cavitation, boiling or an
increased absorption coefficient in the tissue may induce
a thermal drift of the ablative lesion towards the trans-
ducer [8]. Far field of the transducer can also be affected
by thermal heating, especially if a reflective interface is
present [9]. Refraction on pre-focal interfaces [10],l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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tortion of MR guidance images may also yield lateral off-
sets of the effective position of the focal point.
Magnetic resonance guided HIFU (MRgHIFU), in par-
ticular using near real time Proton Resonance Frequency
Shift (PRFS) thermometry (MRT), is at present the only
FDA approved HIFU technology [11]. This approach has
been clinically investigated to treat malignant tumors
using prototype or off-label devices originally dedicated
to uterine fibroid ablation [12-20].
Theoretically, there are no limitations on the lesion
size treatable by MRgHIFU [21]. Sequential MRgHIFU
elementary sonications were evaluated clinically [20], in-
dicating the technical feasibility despite the long treat-
ment times [12-22]. Volumetric MRgHIFU ablation has
also been investigated, demonstrating that a large and
uniform ablation zone can be rapidly obtained using
continuous sonication and mechanical displacement of
the transducer [23,24], interleaved electronic and mech-
anical displacement of the focus [25] or fully electronic
steering of the beam [6]. Moreover, studies using ultra-
sound guidance proposed different methods to increase
the lesion size, such as: inertial cavitation that signifi-
cantly enhanced the heat deposition at the HIFU focus
[26,27], focus splitting for larger coagulations regions
[28] or using a multifocal thoroidal transducer that pro-
duced composite lesions [29,30].
Effective spatial control of an induced thermal lesion
during rapid volumetric ablation should be considered a
major safety issue [9]. Together with the capacity to create
large, rapidly achieved lesions, any volumetric sonication
paradigm must also guarantee accurate spatial control of
the HIFU ablative lesion, with predictable position of the
‘gravity’ center of the ablative region. To our best know-
ledge, available reports are missing providing experimental
data to support that volumetric thermal ablations are in-
deed centered on a specific predefined target in 3D, i.e. a
histological “gold standard” [31].
Different studies describing ballistic markers for HIFU
ablations have already been published. Melodelima et al
[32,33] proposed a tumor-mimicking model made by
injecting a warm solution at 65°C that polymerizes in
hepatic tissue and forms a typically 1 cm size discrete le-
sion that was detectable by ultrasound imaging and
gross pathology. That model was a large unperfused
1 cm hyperechoic lesion on sonograms (US reflecting)
and the polymerized solution had attenuation coefficient
of 0.39 dB.cm−1 at 1 MHz, as compared to 0.68 dB cm-1
for liver parenchyma [34]. Recently, Pichardo et al [35]
proposed using the same agarose-based solution for MR
targeting and thermal monitoring during HIFU sonic-
ation on living static tissue (rabbit muscle). The model
applied to static muscular tissue in rabbits induced sig-
nificant edema probably due to intrinsic temperature ofthe injected solution, while the animals were sacrificed
immediately post-treatment. Therefore, the final dimen-
sions of the lesion and its spatial relation to the ballistic
model were not assessed histologically.
In order to improve and/or to assess spatial control of
ablation, we present here an experimental method to
create a user-defined ballistic target that can be used as
an absolute reference marker prior to any HIFU trials.
The marker must be irreversible, MR compatible and
detectable both in pre-operative MRI and in post-
mortem histology and has to enable the evaluation of
the spatial control achieved during MR-guided HIFU ab-
lation of liver lesions, in particular concerning the le-
sion’s ‘center of gravity’. At the end of the procedure, the
contrast agent/stain must be stably encapsulated in the
intercellular space, where perfusion, diffusion and/or
metabolism are limited or suppressed.
Material and methods
Principle and instrumentation
The marker fixation paradigm consisted of three steps:
1. interstitial RF coagulation of a small region of tissue,
2. injection at the same location of 0.1 mL of a mixture
of methylene blue (Patent Blue V Sodium 2.5%, Guerbet
SA, France) doped with 1% gadolinium-DTPA (Dotarem,
Guerbet, France), and 3. a second RF coagulation, identi-
cal to the first. The role of RF coagulation is to trap the
substance in the tissue by immediately ceasing metabol-
ism and capillary circulation.
A dedicated RF electrode was used for local coagu-
lation and contrast substances injection. This was
designed to operate in monopolar mode and was ma-
nufactured based on 1. a percutaneous entry thin wall
needle 18 G/7 cm (Cook Medical, Bloomington, IN), or
2. radiopaque i.v. catheter 16G/14 cm, (Abbocath-T,
Hospira, Inc, Lake Forest, IL). A square 6 cm2 copper
sheet in contact with the skin (via saline serum) was
used as ground contact (see Figure 1a-c for details). The
catheter is sterile, low cost and individually packaged in
a blister bag, and is for single use only, as is the resulting
home-made RF electrode. The puncture needle is cov-
ered by a polytetrafluoroethylene (PTFE) sheath, which
is an excellent electrical insulator (volume resistivity >
1018 Ωm [36]). The sheath covers the full length of the
puncture needle, excepting its tip (1.2 mm). This PTFE
sheath will isolate the tissue from the electric field,
which will deploy only at the tip of the puncture needle,
thus creating a sharply localized thermal ablation. More-
over, a semi-circular 5 mm long cut was performed at
the proximal edge of the PTFE sheath, where a conduct-
ive clamp made the electrical contact between the punc-
ture needle and the (+) contact of the RF clinical
generator (CelonPOWER, Celon AG, Teltow, Germany)
working at 475 kHz [37].
Figure 1 The dedicated RF needle and ex vivo marker results.
a-c) Monopolar electrode engineered to affix the histological
marker. Note the hemicylindrical proximal cut of the PFTE isolator
sheath (arrow) and electrical clamp at this site. Deployment of the
electrical field around the tip is also illustrated. d). Ex-vivo T1w image
(VIBE 3D isotropic sequence) of four independent thermal lesions
(see red arrows) obtained post-RF ablation. The upper lesions corres-
pond to a coagulated spherical area created without injection of the
Gd-doped staining and the lower lesions were obtained after standard
fixation of the marker, with injection of Gd-doped methylene blue.
e). Macroscopic slice showing the optimal RF thermal lesion, visible as
a white spheroidal volume of colorless tissue (non-injected procedure).
f) - h). Ex vivo macroscopic slices of volumetric MRgHIFU ablation, cut
perpendicular to the focal plane, showing the coagulative lesions
successfully centered on the ballistic target (high intensity blue spot in
three different slices). The prescribed patterns of sonication were 7 x 2
foci, 6 x 2 foci and 3 x 2 foci, respectively, 4 mm inter-foci gap, with a
delivered energy of 18 kJ, 15.4 kJ and 7.7 kJ, respectively.
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ation and visualization of the ballistic model, RF ther-
mal lesions with various parameters were created with
the catheter-based electrode in ex vivo turkey white
meat (degassed during 30 minutes to remove any ex-
ogenous gas bubbles). The lesions were imaged by MR
and further visually examined after the meat sample
was sliced.HIFU system
Ex vivo and in vivo MRgHIFU experiments were con-
ducted with two separate systems. The first system (#1)
used a randomized 256 element phased array transducer
(Imasonic, Besançon, France) operating in the frequency
range from 974 to 1049 kHz, maximum acoustic power
300 W, with a natural focal length and aperture of R =
130 mm and D = 140 mm, respectively. Each active
element of the transducer is a disk of 6 mm diameter.
The HIFU platform uses a programmable 256 channel
generator and a 2D positioning mechanism in the hori-
zontal (XZ) plane (both from Image Guided Therapy,
Pessac, France). Each channel delivers an RF sine wave,
with independent control of the phase, frequency and
amplitude. Electronic steering of the focal point was
available within a -3 dB revolution ellipsoid of axes
30 mm, 30 mm and 50 mm around the natural focus.
The update of phases and amplitudes for the 256 chan-
nels takes less than 10 ms and the focal point position
could be changed 20 times per second to follow any
complex trajectory. The positioning mechanism for the
transducer provides two independent horizontal transla-
tion axes, i.e. X and Z in the magnet frame, within a
displacement range of +/- 80 mm in each direction
with 0.5 mm accuracy. In-house written software pack-
ages for treatment planning and hardware control
were plugged in the real-time kernel of the graphical
user interface (Thermoguide™, Image Guided Therapy,
Pessac, France). Online temperature map displays were
provided by the software interface.
The second HIFU system (#2) used was a research
prototype abdominal HIFU system operating at 1 MHz
and comprising a high density therapeutic array (18 432
elements in a 13 cm× 11 cm rectangular acoustic aper-
ture, element size 0.5 × 1 mm2, Siemens Healthcare, Ultra-
sound Division, Montainview, CA [38,39]. This array was
capable of high acoustic energy flux per unit area (>12
Wac/cm2 average, >25 Wac/cm2 peak; >2 kWac total
average aperture power), significant electronic steering (55
degrees in azimuth and 45 degrees in elevation, no mech-
anical displacement) and also rapidly scanned focal beam
patterns (>1 kHz beam focal point rate). This array was
the acoustic power delivery component in an integrated
software controlled MR guided HIFU system mated to a
Siemens 3 T Trio MRI scanner.
MR imaging
A 3 T whole body MRI scanner (Magnetom Trio a Tim sys-
tem, Siemens AG, Germany, maximum gradient strength =
45 mT/m and maximum slew rate = 200 T/m/s) was used
in the presented study for planning and HIFU temperature
monitoring purposes. A high resolution T1w 3D gradient-
echo (VIBE) acquisition (TE/TR/TA/FA/BW =1.6 ms, 4 ms,
2.55 min, 10°, 650 Hz/Px) was used to predefine the position
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and other adjacent structures. The spatial resolution and
scan time were, respectively 0.8 × 0.8 × 0.8 mm3/2 min 55 s
in static tissue and 1.2 × 1.2 × 1.2 mm3/50 s in liver under
forced apnea. On-line multi-planar high-resolution PRFS-
based MR thermometry [40-42] was used to monitor the
HIFU ablation in real time. Temperature elevation was
monitored using a segmented GRE-EPI sequence [43] with
EPI factor = 11, FOV= 128 mm square (ex vivo) or 200 mm
square (in vivo), voxel size = 1 × 1 × 5 mm (ex vivo) or 1.56 ×
1.56 × 5 mm (in vivo), 3 interleaved slices, TR/TE/FA=
50 ms to 70 ms/9 ms/15°, bandwith = 738 Hz/pixels, tem-
poral resolution 2.5 to 3.5 s. A thermal dose was calculated
using the Sapareto model [44]. The HIFU beam propagated
through the aperture of, respectively, a receive-only 11 cm
diameter loop coil (for ex vivo and rabbit investigations)
positioned in a horizontal plane, or a dedicated 3-element
interventional coil (Clinical MR Solutions, Brookfield, WI,
for liver interventions) wrapped around the animal.
In vivo protocol
All animal procedures were approved by the Geneva
University Institutional Animal Care and Use Committee
and by the Cantonal Veterinary Authority of Geneva.
Blood oxygen saturation, body temperature and exhaled
CO2 were monitored continuously.
Four rabbits (3–4 kg, New Zealand, females) were
premedicated with ketamine (30 mg/kg; Pfizer, Zürich,
Switzerland) and midazolam (0.2 mg/kg; Roche Pharma,
Reinach, Switzerland). After placing an intravenous access
using an ear vein, the rabbits were intubated and mechan-
ically ventilated (Servo Ventilator 900D, Siemens-Elema,
Sweden) using 6-m long ventilation tubing and anesthesia
was maintained by continuous intravenous administration
of 1% propofol (perfusion rate 20 ml/h, Astra Zeneca
AG, Zug, Switzerland) delivered by a distant non MR-
compatible clinical syringe pump (B-D Pilot A; Becton
Dickinson Infusion Systems, Brezins, France). The breath-
ing rate was approximately 40 breaths/min. In addition, to
prevent any contraction of the leg during MRgHIFU abla-
tion, the sciatic nerve of the investigated limb was locally
anesthetized with 1 ml of 1% lidocaine (Bichsel AG,
Interlaken, Switzerland), as well as an i.v. injection of
pancuronium (0.2 mg/kg; Essex Chemie AG, Lucerne,
Switzerland) administered 2 minutes before the MRgHIFU
ablation. For MRgHIFU treatment in the thigh muscle,
the rabbit was positioned in lateral decubitus. The HIFU
system #1 produced the volumetric ablation theoretically
prescribed, to be centered on the created ballistic target.
One marker was produced in each animal followed by
volumetric HIFU ablation. The main parameters of HIFU
ablation in rabbit thigh were: 150 Wac power, 120 sec
duration, duty-cycle nearly 100%, 2 × 5 foci pattern, 4 mm
inter-foci gap.A similar protocol for ballistic marker investigation was
performed in liver in six pigs. Two markers/liver were
produced. In two animals, sonication using MRgHIFU
system #2 and PRFS MR thermometry were performed
under respiratory gating using the optical signal gener-
ated by an in-house built opto-mechanical sensor [45]
attached to the animal’s abdomen. The breathing rate
was approximately 10 breaths/min. Each animal was
positioned prone for sub-xiphoid acoustic access to the
liver parenchyma. Sonication parameters were 450 Wac
power, 60 sec duration, duty-cycle around 50%, 5 mm
diameter disk-like scanning pattern. A single marker
was targeted in each treated animal. Note that acoustic
power values are determined from radiation force cali-
bration prior to MRgHIFU experiments.
After marker fixation (see below) and HIFU ablations
(if any), the animals were awakened and followed up for
7 days. Postoperative analgesia was administered (2 × 0.01
mg/kg/day Buprenorphine, Essex Chemie AG, Lucerne,
Switzerland) during the follow up period. At day 7, the soni-
cated region (thigh or liver) was imaged with Gd-enhanced
T1-weighted MRI and afterwards the animal was sacrificed.
The investigated organ was removed post-mortem and fixed
in 4% formaldehyde. This was further processed for macro-
scopic analysis and microscopic histology. The evaluation of
complication was based on imaging follow-up and necropsy
findings.
Interventional procedure
After local aseptic treatment of the skin, the home-built
monopolar RF electrode was inserted in the animal to
create a marker under US guidance outside the MR
magnet bore. An ultrasonography scanner (Antares,
Siemens Medical Solutions, Mountain view, CA, USA),
equipped with an abdominal CH4.1 phased array im-
aging head was used for both B-mode (frequency range
1.54 to 3.6 MHz) and second harmonic imaging (receive
frequency range between 4 and 4.4 MHz).
The in vivo procedure was performed in a sterile man-
ner by 2 experienced interventional radiologists outside
the MR scanner room with the animal lying supine on
the table. The skin was incised with a scalpel and the
16 G electrode was inserted under real time US guidance
(see equipment above). The electrode was introduced
into the middle of the thigh or in the right hepatic lobe.
For ablation, an average of 4 W was delivered during 15
seconds for each impact (before and after a staining in-
jection). At the end of RF power application, a hypere-
choic area typically 1 cm in diameter on US monitoring
was clearly visible around the electrode tip. This effect
was due to boiling cavitation bubbles [43], and was used
as a per-operatory indicator of sufficient local ablation
around the electrode tip. Note, if the hyperechoic cloud
of bubbles was not visible, the RF ablation was repeated
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was then withdrawn without ablating the needle track
until it reached the hepatic capsule, where a second
marker was generated to obtain a superficial tag, facili-
tating post-mortem identification of the treated hepatic
lobe.
The acoustic properties of the affixed marker were in-
vestigated using the same US imager during the RF abla-
tion and post-RF ablation. The described ballistic model
was further used to mimic a ‘virtual’ tumor-center in
order to assess the spatial control of HIFU ablation
ex vivo and in vivo (sheep and pigs, respectively) on
static and moving tissue. MRI was used interactively to
identify the affixed marker, and hence the volume of tis-
sue to be targeted, using a T1w 3D gradient-echo (VIBE)
sequence (see above). The 3D information was then used
to position the transducer and to calculate the HIFU
beam forming so as to align the focal point with the
marker.
The spatial control of ablation achieved was evaluated
7 days later by comparing the pre-defined position of
the imitated tumor ballistic target and the position of
necrotic and fibrotic areas (i.e. the ‘gravity center’) iden-
tified in contrast-enhanced T1w sequences. Finally, on
post-mortem histology the center of the ablative lesion
was compared to the local marker i.e. fixed methylene
blue staining.
Macroscopic analysis and histology
For macroscopic analysis, the investigated organ was ex-
cised and formalin fixed for 3 weeks. Post-fixation, the
specimen was encapsulated in dual-component polyur-
ethane foam formed into a cubic shape to enable mech-
anical slicing. The entire cube obtained after a 15 min
polymerization period was sliced in 1–1.2 mm thick
slices using a commercially available slicer (Gemma 300,
SIRMAN s.p.a., Pieve di Curtarolo, Italy). Optical scans
(600 to 2400 dpi) of each individual macroscopic slice
were systematically recorded. Co-registration was further
improved using in-house written Matlab code (The
Mathworks Inc, US), if needed, and stack tiff-type im-
ages were generated for further integration and 3D post-
processing using Osirix Software (Osirix Foundation,
Geneva, Switzerland). The chosen macroscopic slices of
interest were quickly investigated on a microscope (HES
staining, Mictotome Leica RM 2135, slice thickness:
5 μm) or frozen at -80°C for further investigation on a
CM3050 cryostat.
Results
The optimal parameters for marker fixation and MR de-
tection were determined to be 2 W RF power during
30 sec, resulting in 60 J energy deposition, with a 18 G
electrode, and 4 W RF power during 15 sec, alsoresulting in 60 J energy deposition, with a 16 G elec-
trode. A higher power level was in general suboptimal as
it triggered impedance cutoff and subsequently smaller
lesions. Figure 1d shows T1-weighted MR images ob-
tained ex vivo after monopolar RF ablation using the
home-built electrode, with and without local injection of
the mixture of methylene blue and Gadolinium chelate.
The marker created by localized energy deposition and
fixation of the contrast agent is clearly visible under MR
and can be conveniently used to pre-define the zone to
be ablated by HIFU, centered on the so-created target.
The size of the histological marker ranged between 2.5
and 4 mm (Figure 1e). To illustrate the marker’s useful-
ness in assessing the spatial accuracy of the thermal le-
sion, we present in Figure 1f-h three independent
examples of ex vivo thermal lesions obtained by volu-
metric MRgHIFU (see the whitened ellipsoidal area in-
side the fresh ex vivo sample), centered on the ballistic
target (high intensity blue spot) within 2 mm spatial ac-
curacy. Some spreading of the methylene blue staining
along the muscle fibers was unavoidable when slicing
the fresh meat across the central plane of the lesion.
However, the color contrast between the native marker
and the spread staining is evident.
During the in vivo interventional procedure of marker
fixation, the ultrasonography clearly visualized the tip of
the RF electrode before ablation (Figure 2a), and the
boiling cavitation during RF ablation (Figure 2b,c). The
precise position of the induced ablation could be chosen
before RF coagulation, based on initial images where the
RF electrode tip is visible. This confirmation in real time
is very useful, making it possible to change the needle’s
position to the preferred point and then fixate the
marker. The occurrence of the “white cavitation” cloud
of bubbles is a direct indication that RF ablation was ef-
fective. The “wash-out” of the cloud bubbles required
approximately one minute after the end-point of RF co-
agulation, as seen in Figure 2d. After the bubbles wash
out, no ultrasound indication of the marker’s presence
could be observed, with standard (retro-diffused, or
back-scattered) ultrasound imaging performed in the fre-
quency range 2-4 MHz, although the experiments were
conducted in optimal conditions ex vivo where the
marker was positioned a few centimeters only from the
imaging transducer. The imaging wavelength at 4 MHz
being approximately 10 times smaller than the marker
itself, missing of any marker signature cannot be attrib-
uted to acoustic diffraction. Therefore this is interpreted
as no significant change in the acoustic impedance in
tissue because of the marker, within the experimental
resolution. This evidence is not covering the thermal ef-
fects involving the absorption of the HIFU beam on the
marker, therefore specific MRgHIFU experiments were
conducted, as described in Appendix.
Figure 2 US images (harmonic imaging) before (a), during (b, c) and after (d) RF ablation in pig liver (please find embedded scale
distance). The electrode alone is visible during the planning period, before RF heating (a, see the red arrow). During RF ablation, the gas bubbles
created around the electrode are clearly seen in the early (b) and late (c) stages of the procedure. No gas bubbles are visible one minute after
the end point of RF ablation due to wash-out with perfusion (d).
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and 7-days post-marker fixation and HIFU therapy in
static tissue, in rabbit thigh. The ballistic target is clearly
seen prior to the HIFU treatment in each section
through the 3D reconstruction (a-c). The apoptotic and
necrotic area formed 7 days after treatment is visible as
a hypo intense signal zone surrounded by a hyper in-
tense rim (d-f ) and corresponds to the planned HIFU
ablation. Methylene blue marker trapped in tissue by
thermo coagulation was clearly detected in different
animals after either 3 weeks (Figure 3h) or 8 months
(Figure 3g) of post-mortem formalin fixation. Frame g is
showing an eccentric lesion with respect to the ballistic
marker as a result of per-operatory HIFU-induced
muscle contraction, detected on line during the treat-
ment (data not shown). Frame h is illustrating a thermal
lesion precisely centered on the ballistic marker when
intra-operatory tissue motion did not occur. The size of
the final HIFU ablations (mean values measured on 4
rabbits), measured at Day 7, after Gd injection, were: in
plane long axis = 30 mm, short axis = 21 mm and height
(parallel to the HIFU beam) = 45 mm.
The ballistic target model was easily detectable in vivo
in pig liver, as a strong hyper-signal in T1w 3D VIBE
images (Figure 4) immediately after fixation, due to the
trapped Gd-based contrast agent. The small volume of
RF coagulated tissue and the trapped tracers induced
no measurable magnetic perturbation in the phase
maps acquired with the PRFS temperature-sensitive
GRE-EPI sequence during HIFU sonication. This behaviorenables the direct use of reference-free PRFS-calculated
temperature maps [46,47] without any correction specific
to the marker. Seven days after the marker procedure, the
thermal lesions induced by RF ablation could be identified
in freshly cut liver samples (Figure 5a,b). Macroscopic
slices indicated a blue-to-green colored volume of coagu-
lated tissue (frame a) for the methylene blue stained ballis-
tic marker and a whiter zone (frame b) for a case without
methylene blue. No methylene blue was detected outside
the RF-ablated tissue, indicating normal clearance of the
un-trapped staining. Post-mortem macroscopic illustration
(frames c and d) and microscopic histology (frame e, same
lesion as shown in frame d) of the ballistic marker (inside
the lobe – c, and at the periphery of the lobe - d and e)
after 3 weeks of formalin fixation clearly indicates the
ablated zone surrounded by healthy tissue. Histopath-
ology indicated a complete disorganization of hepato-
cytes and the absence of red cells due to the sinusoids
destruction in the center of the marker. More periph-
erically, intra-cellular edema was found. The lesion was
sharply delineated by a few hundred microns thick
fibro-inflammatory rim. The rest of the hepatic paren-
chyma had a normal aspect, with clear delineation of
lobuli and no visible side effects due to the interven-
tional procedure. Please note that no HIFU sonication
was performed in the examples illustrated in Figures 4
and 5. For in vivo studies, the marker was imaged (T1w
VIBE MR sequence) in situ at 10 and 80 minutes after
RF procedure, and no alteration was detected between
these 2 time points.
Figure 3 (See legend on next page.)
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Figure 3 In vivo ballistic marker in rabbit thigh followed by HIFU sonication. a) - c): T1w 3D (VIBE) images of the ballistic target model,
shown in situ just before MRgHIFU sonication. The sagittal (feet first), coronal and axial planes are shown from left to right, respectively. The
RF-affixed marker appears as a bright spot. d) - f): Gd-enhanced T1w 3D (VIBE) images 7 days post-treatment of the same animal, showing the
necrotic and fibrotic lesion. The multi planar reconstruction crossing point indicates the approximate position of the pre-defined ballistic target
model. g) Macroscopic findings corresponding to the same rabbit treatment (3 weeks formalin fixation, followed by toluene bath dehydration
and 8 months conservation). The piece was sliced along the sagittal plane (head first) and the dashed contour delineates the ablative lesion.
The methylene blue staining is seen to be misaligned with the center of the actual MRgHIFU thermal lesion by approximately 1 cm. Coagulation
necrosis showed a complete loss of striation (down in the corner, zoomed view). h) Macroscopic illustration of another rabbit thigh sliced after 3
weeks post mortem formalin fixation. The MRgHIFU volumetric lesion (delineated manually by dots) is here perfectly centered on the ballistic
target model, the latter visible as a dark stained spot.
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in pig liver is shown in Figure 6. Temperature (a-c) and
thermal dose maps (d-f ) in three different planes indi-
cate the thermal build-up accumulation at the end of the
HIFU sonication. Seven days after the treatment, after
Gd administration, the final lesion (g-i) could be easily
identified in T1w VIBE images. Moreover, the lesion was
also identified in post-mortem macroscopic (j) and
microscopic analysis (l), having a similar ablation shape.
In frame j the two ablated regions are easily distin-
guished: the blue arrow indicates the RF coagulated
marker (identified by the presence of methylene blue),
positioned peripheral to the HIFU ablation, delimited by
a dotted red line. Microscopic histology (frame l) re-
vealed a clear difference between the ablated zone and
healthy tissue, with normal cells showing clear striation
by hematoxilin-eosin staining, as well as peripheral nu-
clei, while areas of coagulation necrosis appeared with
lighter staining and showing a complete loss of lobular
structure. A 3D reconstruction (Osirix Software) of the
hepatic lobe containing the final lesion (same as in
frame j) is shown in frame k, indicating the HIFU lesionFigure 4 T1w 3D (VIBE) images of the ballistic target model obtained
square for a) - c) and 90 mm square for d) - f)). Note the strong T1 con
(b, e) and axial (c, f). Zoomed images (x3) are shown in frames d) - f).and the RF marker at the periphery. The shortest
distance between the centers of the two lesions was
5 mm. The calculated volume of the HIFU lesion was
1.935 cm3, while the volume of the created marker was
0.0235 cm3 in the presented case.
Discussion
We describe here a new method to create a user-defined
ballistic target that can be used as an absolute reference
marker, based on trapping a mixture of gadolinium che-
late and methylene blue (hystology stain) and using
sharply localized RF energy deposition, causing immedi-
ate cell death and coagulation. The gadolinium-based
contrast agent was easily detectable by pre-operative MR
imaging; therefore, this method provided a minimally in-
vasive and robust ballistic target, mimicking a small ‘vir-
tual’ tumor, and can be conveniently used as a target for
MRgHIFU ablations. According to pathologists, the
methylene-blue does not affect the microscopic histology
staining, while it is trapped within the coagulated tissue.
The large majority of pre-clinical and clinical studies
using MR-guided HIFU technology are reportingin a pig liver, 10 minutes after its fixation (shown FOV is 270 mm
trast of the target, easily detectable in all slices: sagittal (a, d), coronal
Figure 5 Post-mortem findings of different ballistic markers created in pig liver. a), b) The liver was freshly cut at Day 7, while the marker
was created either with injected methylene blue (a) or without methylene blue injection (b). c), d) Macroscopic illustration of the ballistic marker
after 3 weeks of formalin fixation. The RF lesions correspond to spheroid areas of ablation surrounded by healthy tissue in frames a) -c). The RF
ablation shown in frame d) was performed at the liver periphery and corresponds exactly with the microscopic histology, illustrated in frame
e) (see embedded distance scale). The FOV shown in frames a) - c) is 15 × 15 mm and in frame d) is 15 × 20 mm.
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the boiling regime is likely to produce local disruption
of the magnetic susceptibility [9,43] and thus errors in
PRFS MR thermometry. A sharp RF coagulation is re-
quired whenever the HIFU treatment does not result in
immediate necrosis, because the HIFU-induced apoptosis
in the treated area does not prevent wash out of the stain-
ing until all metabolism ceases. We demonstrated that
methylene blue was trapped by immediate coagulation of
the tissue using localized RF energy deposition, and that
any un-trapped staining was cleared all around, including
from inside the HIFU-ablated tissue. Staining was detect-
able immediately after animal sacrifice (see Figure 5), after
3 weeks of formalin fixation (see Figure 6) and also after
eight months of formalin fixation (see Figure 3). This
demonstrates a highly stable histology marker, compatible
with semi-chronic follow up protocols, where the living
tissue may deform during the time the animal is allowed
to survive after sonication. No local or systemic complica-
tions related to the marker were noticed in 10 animals
during the survey period of 7 days. The minimally invasive
interventional procedure observing sterile conditions
should be at low risk.
During RF ablation, boiling bubbles in the tissue were
easily detected with ultrasonography, during approxi-
mately one minute after the end-point of RF ablation in
pig liver (see Figure 2). Beyond this transient period, the
created target did not modify the local echogenicity of
tissue in the range 1.57 - 4.4 MHz, nor the local mag-
netic susceptibility (neutral versus PRFS thermometry)
and induced no observable side effects in tissue. Themarker involves tissue coagulation and injection of a
small volume of stable liquid state solutions, while its
size is comparable to the wavelength of HIFU. These
conditions yield the minimal acoustic perturbation of
HIFU beam – if any – by a marker that is conveniently
visualized with conventional resolution T1-weigthed MR
sequences. If no HIFU ablation of tissues surrounding
the marker is performed, the small coagulative volume
of the marker itself is very likely to be reabsorbed by the
tissue in the long term. Due to real time US visualization
of the electrode tip while the operator manipulates the
needle towards the investigated zone, a major advantage
of this ballistic marker is the ability to choose the precise
position of the induced ablation. If the needle is not at
the right place, the operator can alter the position until
the optimal position is reached before delivering the RF
energy. Another advantage of this model can be consid-
ered the possibility of creating multiple markers in the
same organ, due to the time effective procedure and to
their point-like aspect. The RF electrode can be reposi-
tioned in the organ, or removed completely, changed
and inserted again in the body using another entry point.
The effectiveness of ablation is confirmed with US de-
tection of white cavitation, while staining is confirmed
by MR imaging of trapped Gd from the same mixture.
Correct evaluation of what tissue is ablated by HIFU
sonication and precise determination of HIFU-induced
lesion position versus the treatment planning cannot be
done if the animal is sacrificed immediately post-
treatment. Therefore, for our study, the animals were
followed up for 7 days. Histological analyses both
Figure 6 In vivo ballistic marker in pig liver followed by HIFU sonication. Temperature elevation (°C) (a-c) and lethal thermal dose
(>240CEM43) maps (d-f) obtained at the end of HIFU sonication in pig liver. g) - i) T1w VIBE images of the final lesion (HIFU and RF ablation) in pig
liver, at Day 7 after Gd administration. j) Post-mortem macroscopic illustration of the ballistic marker and HIFU ablation after 3 weeks of formalin
fixation. The difference between the 2 lesions is visible due to the blue coloration of the ballistic marker. FOV = 20 × 20 mm. k) 3D reconstruction of
the liver lobe containing the HIFU lesion and the ballistic marker illustrated in frame j: entire HIFU lesion (elongated shape, in red) and the RF marker
(in blue) at the periphery; l) microscopic histology, same slice as shown in frame j).
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types of lesions (ballistic marker and HIFU ablation).
This can indicate, post-treatment, whether the HIFU le-
sion was centered on the target or not. Moreover, vari-
ous prefocal thermo-acoustic effects (like thermal drift
induced by cavitation or differential absorption in the
traversed tissues) may be evidenced with this approach.Accurate targeting in abdominal organs during breath-
ing is a challenging problem. Unlike previous reports
dealing with static conditions during the sonication
[32,35], our sonications in pig liver were performed
under continuous breathing and gating. Internal organ
drift between targeting and sonication steps [48], acous-
tic aberration of the HIFU beam versus the theoretical
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tortion of MR images sequence-specific are inherent
limits to the achievable accuracy for centering the le-
sions on the T1-contrast marker. Here, a larger popula-
tion for in vivo quantitative assessment of the targeting
accuracy with the available MRgHIFU device was not
defined as a goal.
The presented method demonstrated no risk of tissue
contamination with air bubbles and no irregular heating
pattern was observed on PRFS temperature maps during
HIFU sonication, as opposite to [35]. Importantly, the nee-
dle and the syringe were mounted together and filled with
liquid solution prior to the incision. The interventional
procedure to fix the marker here was safe and successfully
performed in all cases within approximately 15 minutes.
No specific training was requested for the interventional
radiologist. The very low volume of injected liquid was de-
livered at room temperature and no physical or chemical
transformation will occur spontaneously after some crit-
ical period of time. Thus, there is no constrained timing
for executing the interventional procedure. This is particu-
larly important to allow the interventionist sufficient time
to accurately perform the image guided positioning of
the electrode. Tissue effraction is minimal and direct as-
sessment of the ballistic accuracy of millimeter-range
(i.e. elementary) HIFU lesions aiming to overlap theFigure 7 Appendix. Example of precise targeting of a marker with elemen
thermometry (b) images showing the marker and the trajectory of the RF
(blue plot) and in bulk tissue away from the marker (black plot) and a cam
ballistic marker.marker location is meaningful due to the small size of the
marker itself, unlike the previous model [32,35].
There are different applications where the presented
marker model may be suitable. The presented ballistic
model is expected to be a convenient procedure to valid-
ate the accuracy of HIFU ablation in any organ, static or
mobile. Beside tissue-dependent or device-dependent
targeting errors, the entire problem of motion tracking
errors in moving targets can further tackled.
Other applications of our affixed marker may involve
minimally invasive tissue ‘tattooing’ as landmarks for dis-
eased tissue/tumor or healthy structures at risk to be de-
lineated for surgery, for instance “missing metastasis”.
Current preoperative marking techniques to guide radio-
therapy or surgery include guide wire locators (with the
associated risks of migration, transection and scheduling
conflicts), radioactive injections [49,50] and charcoal sus-
pensions [51], which are invasive. Radiotherapy is often
guided using external tattoos and internal clips in tumor
beds or at biopsy sites. Substituting the methylene blue
staining with a radio-opaque agent (e.g. iodine-based) may
render the marker visible to X-Ray techniques.
Multi-modal imaging contrast agent can also be con-
sidered for ablative trapping using the methodology de-
scribed in this paper (e.g. correlation of PET with MR
images). The coagulating energy applied here was radiotary HIFU sonication: T1-w VIBE (a) and in situ magnitude GRE-EPI
needle; temperature elevation (c) during HIFU sonication on a marker
era picture (d) of the elementary HIFU lesion centered on the
Petrusca et al. Journal of Translational Medicine 2014, 12:12 Page 12 of 13
http://www.translational-medicine.com/content/12/1/12frequency, but laser ablation devices (LITT) may also be
used with an appropriate design of the delivery tool.Conclusion
HIFU is fundamentally a propagating wave with a lim-
ited precision of a-priori prediction of the focus position
in tissue during sonication. We presented here an ex-
perimental method to investigate the targeting accuracy
of MR-guided focused ultrasound ablation, by fixing a
ballistic target detectable with both pre-operative MR
and post-mortem histology. The marker’s ultrasound
conspicuity was below the detection threshold on a clin-
ical ultrasound imager. The marker was established
irreversibly, induced no changes in local magnetic sus-
ceptibility and its size was comparable to the HIFU
wavelength. It showed no side effects in tissue and can
be considered as a long-term stable histology staining
method.Appendix
Investigation of marker’s influence on elementary
sonication induced thermal build-up
Specific experiments were designed and performed, con-
sisting of targeting the marker with single focus elemen-
tary HIFU sonication while guaranteeing high targeting
precision, as both the marker and the elementary lesion
were small. To achieve high ballistic precision, we have
labeled with MR contrast agent and visual staining not
only the marker but also the trajectory of the RF needle
serving as electrode (Figure 7a). Moreover we have
checked the marker’s position not only on the planning
3D image but also on the magnitude of GRE-EPI therm-
ometry images in situ (Figure 7b), controlling that a low
energy pilot sonication yielded PRFS phase shift at the
correct location prior to high energy ablation (108 W,
30 s). An example of accurate targeting of a marker with
elementary sonication is provided in Figure 7d. Under
these strictly controlled conditions, on four repeated ex-
periments in two samples of ex vivo Turkey breast
muscle, we could not measure any significant influence
of the marker on the MR temperature elevation versus
heating bulk tissue away of the marker, see Figure 7c.
For best robustness, the thermal comparison on vs. out
of marker was performed with mechanical 2D transla-
tion of the transducer and invariant electronic beam
forming. Considering the effective volume of the RF ab-
lated tissue produced with the marker and, respectively,
the effective volume of an elementary HIFU ablation, it
appears macroscopically that the presence of the marker
has not a measurable influence on the thermal build up.
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